Discover how Lightship’s hybrid clinical trial model successfully accelerated enrollment for a Phase III cardiovascular study while expanding access, choice, and equity. Partnering with a top 10 global pharmaceutical company, Lightship leveraged its curated site network and experienced mobile research nurses to deliver a seamless trial experience that reduced patient burden and expanded reach.

By integrating in-clinic and off-site visits, Lightship enabled participation from individuals living over 60% farther from study sites than typical participants. This approach not only boosted enrollment capacity but also improved participant diversity - engaging more Black, African American, Hispanic, and Latino individuals than the national average for cardiology trials.

Through patient-centric design and strong operational alignment with site teams, Lightship ensured consistent oversight, high retention rates, and a smooth transition between visit modalities. The result was an accelerated recruitment timeline that exceeded sponsor goals and enhanced the overall participant experience.

What You’ll Learn from This Case Study

• How hybrid trial design expands reach and participant representation
• The critical role of our site network and mobile nurses in accelerating enrollment
• Strategies for enhancing diversity and retention
• Key outcomes, including a 60% increase in participant distance and 95% retention for off-site visits